Institut Curie

Research facility


Location: Paris, France (FR) FR

ISNI: 0000000406396384

ROR: https://ror.org/04t0gwh46

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy (2023) Claps F, van de Kamp MW, Mayr R, Bostrom PJ, Shariat SF, Hippe K, Bertz S, et al. Journal article Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis (2022) Guyon J, Fernandez-Moncada I, Larrieu CM, Bouchez CL, Pagano Zottola AC, Galvis J, Chouleur T, et al. Journal article The emergence of spontaneous coordinated epithelial rotation on cylindrical curved surfaces (2022) Glentis A, Blanch-Mercader C, Balasubramaniam L, Saw TB, d'Alessandro J, Janel S, Douanier A, et al. Journal article PHARMACOKINETICS AND SAFETY OF TOPICAL VS ORAL ADMINISTRATION OF AMITRIPTYLINE HYDROCHLORIDE-IMPLICATIONS FOR NEUROPATHIC PAIN (2022) Ellrich J, Catus F, Greco C, Lokiec F, Picaut P Conference contribution Improved 3D tumour definition and quantification of uptake in simulated lung tumours using deep learning (2022) Dal Toso L, Chalampalakis Z, Buvat I, Comtat C, Cook G, Goh V, Schnabel JA, Marsden PK Journal article Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group (2022) Bakhuizen JJ, Hanson H, Van De Tuin K, Lalloo F, Tischkowitz M, Wadt K, Doergeloh BB, et al. Conference contribution Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients (2022) Mertens LS, Claps F, Mayr R, Bostrom PJ, Shariat SF, Zwarthoff EC, Boormans JL, et al. Journal article Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study (2022) Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, et al. Journal article The 3rd ESTRO-EFOMP core curriculum for medical physics experts in radiotherapy (2022) Garibaldi C, Essers M, Heijmen B, Bertholet J, Koutsouveli E, Schwarz M, Bert C, et al. Journal article Salivary Gland Carcinoma in Children and Adolescents: The Expert/Partner Diagnosis and Treatment Recommendations (2021) Bisogno G, Schneider D, Ferrari A, Stachowicz-Stencel T, Rascon J, Synakiewicz A, Agaimy A, et al. Conference contribution